Inventor · disambiguated record
Henrik Mueller
Also filed as: MUELLER HENRIK
7 granted patents·7 pending applications·45 citations·filing 1993–2025
83Inventor score
Top patents by PatentIndex Score
14 records- 0191US10953034B2Nucleic acid molecule for reduction of PAPD5 and PAPD7 mRNA for treating hepatitis B infectionHOFFMANN LA ROCHE·Filed 2018·Granted Mar 23, 2021·5 cites·24 claims
- 0290US12303525B2Nucleic acid molecule for reduction of PAPD5 and PAPD7 mRNA for treating hepatitis B infectionHOFFMANN LA ROCHE·Filed 2022·Granted May 20, 2025·1 cites·41 claims
- 0388US11484546B2Nucleic acid molecule for reduction of PAPD5 and PAPD7 mRNA for treating hepatitis B infectionHOFFMANN LA ROCHE·Filed 2019·Granted Nov 1, 2022·3 cites·36 claims
- 0487US11191775B2PAPD5 and PAPD7 inhibitors for treating a hepatitis B infectionHOFFMANN LA ROCHE·Filed 2017·Granted Dec 7, 2021·2 cites·8 claims
- 0585US11534452B2Nucleic acid molecules for reduction of PAPD5 or PAPD7 mRNA for treating hepatitis B infectionHOFFMANN LA ROCHE·Filed 2017·Granted Dec 27, 2022·2 cites·18 claims
- 0677US2023210887A1Nucleic acid molecules for reduction of papd5 or papd7 mrna for treating hepatitis b infectionHOFFMANN LA ROCHE·Filed 2022·Application pending·0 cites
- 0775US2025319114A1NUCLEIC ACID MOLECULE FOR REDUCTION OF PAPD5 AND PAPD7 mRNA FOR TREATING HEPATITIS B INFECTIONHOFFMANN LA ROCHE·Filed 2025·Application pending·0 cites
- 0873US2022096527A1Papd5 and papd7 inhibitors for treating a hepatitis b infectionHOFFMANN LA ROCHE·Filed 2021·Application pending·0 cites
- 0965US2025263705A2Pharmaceutical combinations for treatment of hbvLUANGSAY SOUPHALONE·Filed 2024·Application pending·0 cites
- 1062US2023357773A1Oligonucleotide treatment of hepatitis b patientsHOFFMANN LA ROCHE·Filed 2023·Application pending·0 cites
- 1159US2023119360A1Pharmaceutical combination of a therapeutic oligonucleotide targeting hbv and a tlr7 agonist for treatment of hbvHOFFMANN LA ROCHE·Filed 2022·Application pending·0 cites
- 1257US2023123601A1Pharmaceutical combination of antiviral agents targeting hbv and/or an immune modulator for treatment of hbvHOFFMANN LA ROCHE·Filed 2022·Application pending·0 cites
- 1352US5453984ACommunication system for multi-service communication terminal equipment in local networksSIEMENS AG·Filed 1993·Granted Sep 26, 1995·29 cites·20 claims
- 1431US5859855ANetwork emulator for private communication terminal equipmentSIEMENS AG·Filed 1996·Granted Jan 12, 1999·3 cites·17 claims
Join the waitlist — get patent alerts
Get an alert when Henrik Mueller files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →